Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic Acetylcholine Receptor Antagonists
摘要:
A novel 4-hydroxyl(diphenyl)methyl substituted quinuclidine series was discovered as a very promising class of muscarinic antagonists. The structure-activity relationships of the connectivity of the diphenyl moiety to the quinuclidine core and around the ring nitrogen side chain are described. Computational docking studies using an homology model of the M-3 receptor readily explained the observed structure-activity relationship of the various compounds. Compound 14o was identified as a very potent, slowly reversible M-3 antagonist with a very long in vivo duration of bronchoprotection.
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
本发明提供了肌肉型乙酰胆碱受体拮抗剂及其使用方法。
Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
申请人:Glaxo Group Limited
公开号:US07767691B2
公开(公告)日:2010-08-03
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
本发明提供了肌肉型乙酰胆碱受体拮抗剂及其使用方法。
MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
申请人:GLAXO GROUP LIMITED
公开号:EP1937068A2
公开(公告)日:2008-07-02
US7767691B2
申请人:——
公开号:US7767691B2
公开(公告)日:2010-08-03
[EN] MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RECEPTEURS D'ACETYLCHOLINE MUSCARINIQUE
申请人:GLAXO GROUP LTD
公开号:WO2007022351A2
公开(公告)日:2007-02-22
[EN] Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. [FR] L'invention concerne des antagonistes de récepteurs d'acetylcholine muscarinique et des procédés de leur utilisation.